x

Posted 30 January, 2023

TECOGEN INC. appointed Dr. Abinand Rangesh as new CEO

OTC:TGEN appointed new Chief Executive Officer Dr. Abinand Rangesh in a 8-K filed on 30 January, 2023.


  On January 30, 2023, Tecogen Inc. (the "Company") issued a press release announcing that the Company's Board of Directors appointed Dr. Abinand Rangesh to serve as the CEO of the Company effective January 30, 2023.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of TECOGEN INC.
Real Estate/Construction • Building Materials/Products
Tecogen, Inc. engages in the production of commercial and industrial, natural-gas-fueled engine-driven, and combined heat and power (CHP) products. It operates through the Products, Services, and Energy Production segments. The Products segment designs, manufactures, and retails industrial and commercial cogeneration systems. The Services segment installs and maintains the cogeneration systems. The Energy Production segment sells energy in the form of electricity, heat, hot water, and cooling to customers under long-term sales agreements. The company was founded by George N. Hatsopoulos and John N. Hatsopoulos in 1987 and is headquartered in Waltham, MA.
Market Cap
$17.9M
View Company Details
TECOGEN INC. by TradingView
Relevant filing section
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.


On January 30, 2023, Tecogen Inc. (the "Company") issued a press release announcing that the Company's Board of Directors appointed Dr. Abinand Rangesh to serve as the CEO of the Company effective January 30, 2023. Dr. Rangesh will also continue to serve as the CFO of the Company. A copy of the press release is attached as Exhibit 99.01. Also on January 30, 2023 Benjamin M. Locke resigned as CEO and as a director of the Company and its affiliates effective January 30, 2023 and entered into a Consulting Agreement with the Company pursuant to which he will continue to be available for consultation with management of the Company.


The information in Exhibit 99.01 to this Current Report on Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such a filing.